Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
- Resource Type
- Periodical
- Source
- The Lancet Gastroenterology & Hepatology; August 2017, Vol. 2 Issue: 8 p565-575, 11p
- Subject
- Language
- ISSN
- 24681253